What question did this study set out to answer?

To report a novel BSCL2 variant and its associated clinical features in a patient with congenital generalized lipodystrophy type 2.

May 7, 2026Open Access

Clinical, genetics and in silico analysis of a novel BSCL2 variant in a patient with CGL2 from Iranian Azeri Turkish ethnic group: expanding the genotypic spectrum through a comparative review

Key Points

To report a novel BSCL2 variant and its associated clinical features in a patient with congenital generalized lipodystrophy type 2.
Clinical and genetic analysis of an 18-year-old female patient
In silico analysis of the BSCL2 variant
Comparative review of relevant literature
Identified a novel frameshift variant NM_001122955.4:c.828_835dup p.(Arg279ProfsTer21)
Patient exhibited severe lipoatrophy, muscular hypertrophy, and insulin resistance
Findings expand the BSCL2 mutational spectrum and highlight genetic analysis importance in consanguineous populations

Abstract

Congenital generalized lipodystrophy type 2 is a rare autosomal recessive disorder caused by mutation in the BSCL2 gene. Here we report a novel variant (NM₀01122955. 4: c. 828₈35dup p. (Arg279ProfsTer21) ) in an 18-year-old female with congenital generalized lipodystrophy type 2. The patient presented with severe lipoatrophy, muscular hypertrophy and insulin resistance. This frameshift variant introduces a premature stop codon, probably triggering nonsense-mediated decay. This finding expands the BSCL2 mutational spectrum and highlights the importance of genetic analysis in consanguineous populations.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Bazmi et al. (Mon,) studied this question.

synapsesocial.com/papers/69fbefef164b5133a91a41df https://doi.org/https://doi.org/10.1038/s41439-026-00350-6

Bookmark

View Full Paper